Dosing of Unfractionated Heparin for Thromboprophylaxis

Standard Dosing Regimen

The American Heart Association recommends 5,000 units of unfractionated heparin subcutaneously every 8 hours for surgical and oncologic patients 1, 2, 3
The standard dosing regimen of 5,000 units every 8 hours provides a more consistent anticoagulant effect and greater reduction in the incidence of deep vein thrombosis compared to dosing every 12 hours 2
For medical patients at moderate risk, a regimen of 5,000 units every 12 hours is acceptable, but provides less robust protection 2

Initiation of unfractionated heparin 2 hours before surgery is recommended for surgical patients to achieve adequate anticoagulation at the time of highest thrombotic risk 2
Continuation of unfractionated heparin for at least 7-10 days postoperatively or until the patient is fully ambulatory, whichever is longer, is recommended 1, 2
For oncologic patients undergoing major abdominal or pelvic surgery, extended prophylaxis beyond 10 days should be considered due to their persistently elevated thrombotic risk 2

Unfractionated heparin is the agent of choice when creatinine clearance is <30 mL/min, as it is primarily metabolized by the liver rather than excreted renally 1, 2, 4
The standard dosing regimen of 5,000 units every 8 hours can be used without dose adjustment in renal insufficiency 2
For creatinine clearance <15 mL/min, unfractionated heparin 5,000 units every 8-12 hours subcutaneously may be used based on body mass index 4

For patients with weight >100 kg or BMI >30 kg/m², consideration of intermediate doses such as unfractionated heparin 7,500 units every 8 hours or enoxaparin 40 mg every 12 hours is recommended 1
The French guideline recommends unfractionated heparin 5,000 units every 8 hours for patients with BMI >30 kg/m² instead of higher doses 4

Unfractionated heparin 5,000 units subcutaneously every 8 hours is the specifically recommended regimen for venous thromboembolism prophylaxis in cancer patients 1, 2
For high-risk oncologic surgery, consideration of low-molecular-weight heparins in high prophylactic doses as an alternative is recommended 2

Anticoagulants should not be administered within 10-12 hours of neuroaxial anesthesia due to the risk of spinal hematoma 2
Platelet count should be monitored every 2-3 days from day 4 to day 14 in patients at risk of heparin-induced thrombocytopenia 2
Unfractionated heparin should not be used in patients with active heparin-induced thrombocytopenia or a history of it; a direct thrombin inhibitor or fondaparinux should be used instead 2
Routine monitoring of anti-Xa levels is not required for most patients on prophylactic doses, but should be considered in patients with extreme body weights or renal insufficiency 1